Company News: Page (1) of 1 - 09/04/12

Aegerion Pharmaceuticals Announces Participation at Morgan Stanley and Think Equity Healthcare Conferences

(September 04, 2012)

CAMBRIDGE, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Morgan Stanley Global Health Care Conference in New York City. Marc D. Beer, CEO of Aegerion, is scheduled to present on Tuesday, September 11, 2012 at 4:30 p.m. ET.

Aegerion will also participate in the Think Equity G9 Annual Growth Conference in New York City. Mr. Beer is scheduled to present on Wednesday, September 12, 2012 at 3:00 p.m. ET.

The presentations will be webcast live and may be accessed for 90 days following the conference by visiting the "Investors" section of Aegerion's website, www.aegerion.com.

About Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) is an emerging biopharmaceutical company focused on the development and commercialization of novel, life-altering therapeutics to treat debilitating and often fatal rare diseases. Aegerion is motivated by its commitment to patients first. We are also attentive to our core values of integrity, innovation, responsibility to healthcare providers, development of employees and always – scientific and clinical excellence.

CONTACT: Aegerion Pharmaceuticals, Inc.
Michael Lawless, VP, IR
857-242-5028

LaVoie Group
Amanda Murphy
978-745-4200 X103

Page: 1

Related Keywords: PHARMACEUTICALS, WEBCASTPro AV, Presentors, Business Issues, Internet Media, Presentation, Events, webcast, Inc., healthcare, Surgery, Lifestyle, Medical,